Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1131-1140 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|January 20, 2022
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cellsEmeric Limagne, Lisa Nuttin, Marion Thibaudin, et al.
Cancer Cell|December 31, 2021
B cells secrete GABA, which provokes a pro-tumor immune microenvironmentMara Gilardi, Monika Ramos, Daniel Hollern
Cancer Cell|December 15, 2021
Toward a better understanding of T cells in cancerDavid Y Oh, Lawrence Fong, Evan W Newell, et al.
Cancer Cell|November 9, 2021
A rare insight into the immunosuppressive landscape of prostate cancer bone metastasesClaudia Palena, James L Gulley
Cancer Cell|November 9, 2021
Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapyPaul Yenerall, Ralf Kittler, John Minna
Cancer Cell|January 11, 2022
LTK fusions: A new target emerges in non-small cell lung cancerAlissa J Cooper, Lecia V Sequist, Ted W Johnson, et al.
Cancer Cell|February 9, 2021
A Malignant Case of Arrested Development: Cancer Cell Dormancy Mimics Embryonic DiapauseYu-Hsuan Lin, Hao Zhu
Cancer Cell|February 9, 2021
Not All Tumor-Infiltrating CD8<sup>+</sup> T Cells Are Created EqualWerner Held, Daniel E Speiser
Cancer Cell|February 9, 2021
Heterogeneity in Metastatic Potential of Cancer Cells Is Revealed En MassePavitra Viswanath, Alana L Welm
Cancer Cell|September 24, 2019
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, et al.
Pageof 383

Showing results (1131-1140 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|January 20, 2022
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cellsEmeric Limagne, Lisa Nuttin, Marion Thibaudin, et al.
Cancer Cell|December 31, 2021
B cells secrete GABA, which provokes a pro-tumor immune microenvironmentMara Gilardi, Monika Ramos, Daniel Hollern
Cancer Cell|December 15, 2021
Toward a better understanding of T cells in cancerDavid Y Oh, Lawrence Fong, Evan W Newell, et al.
Cancer Cell|November 9, 2021
A rare insight into the immunosuppressive landscape of prostate cancer bone metastasesClaudia Palena, James L Gulley
Cancer Cell|November 9, 2021
Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapyPaul Yenerall, Ralf Kittler, John Minna
Cancer Cell|January 11, 2022
LTK fusions: A new target emerges in non-small cell lung cancerAlissa J Cooper, Lecia V Sequist, Ted W Johnson, et al.
Cancer Cell|February 9, 2021
A Malignant Case of Arrested Development: Cancer Cell Dormancy Mimics Embryonic DiapauseYu-Hsuan Lin, Hao Zhu
Cancer Cell|February 9, 2021
Not All Tumor-Infiltrating CD8<sup>+</sup> T Cells Are Created EqualWerner Held, Daniel E Speiser
Cancer Cell|February 9, 2021
Heterogeneity in Metastatic Potential of Cancer Cells Is Revealed En MassePavitra Viswanath, Alana L Welm
Cancer Cell|September 24, 2019
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, et al.
Pageof 383